NCT04929496

Brief Summary

The purpose of this study is to assess whether the use of physiology parameters as guidance post-percutaneous coronary interventions (PCI) is associated with less risks of target vessel failure (TVF) and angina-related events than standard angiographic guidance.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
221

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 18, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

September 10, 2021

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

March 19, 2025

Status Verified

January 1, 2025

Enrollment Period

4.3 years

First QC Date

May 31, 2021

Last Update Submit

March 14, 2025

Conditions

Keywords

Coronary Artery DiseaseFractional Flow ReservePost-PCI FFRAngiographyAngioplasty

Outcome Measures

Primary Outcomes (2)

  • Rate of Target Vessel Failure

    as the composite of cardiac death, lesion-related MI and target vessel revascularization

    within 18 months after index PCI;

  • Rate of angina-related events

    defined as hospitalization for unstable angina and unsolicited medical visits for angina

    within 18 months after index PCI;

Secondary Outcomes (6)

  • Final post-PCI pressure ratio values according to lesion location and intervened vessels

    Post-randomization after stent implantation (< 1 hour)

  • Final post-PCI FFR values according to lesion location and intervened vessels

    Post-randomization after stent implantation (< 1 hour)

  • Final post-PCI dPR values according to lesion location and intervened vessels

    Post-randomization after stent implantation (< 1 hour)

  • Final post-PCI physiology pullback curves according to lesion location and intervened vessels

    Post-randomization after stent implantation (< 1 hour)

  • Rates of unstable angina requiring hospitalization or unsolicited medical visits

    within 18 months of index procedure

  • +1 more secondary outcomes

Study Arms (2)

Angiographical guidance only

NO INTERVENTION

Standard of care

Post-PCI FFR guidance

EXPERIMENTAL

Post-PCI Fractional Flow Reserve and non-hyperemic pressure ratios measurement

Procedure: post-PCI FFR

Interventions

post-PCI FFRPROCEDURE

final invasive physiology measurements after successful stent implantation, followed by functional optimization if physiology indexes remain positive.

Also known as: Fractional Flow Reserve, Non-hyperemic pressure ratios
Post-PCI FFR guidance

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient referred for diagnostic coronary angiography and / or possible PCI in native coronary vessels.
  • Successful (\< 30% diameter stenosis and normal TIMI 3 flow post-stenting) and uncomplicated PCI
  • All treated lesions stented with drug-eluting stents (except side-branches of bifurcations)

You may not qualify if:

  • Lesion in saphenous vein or arterial grafts
  • Allergy to aspirin, thienopyridines or ticagrelor precluding treatment for 30 days
  • Sub-optimal PCI result ( \>30% residual diameter stenosis and/or \<TIMI3 flow) or peri-procedural complications
  • Acute ST-Elevation MI (culprit lesion)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IUCPQ - Laval Hospital

Québec, Quebec, G1V 4G5, Canada

Location

Related Publications (1)

  • Ulacia Flores P, Cieza T, Ouarrak S, Ruhl A, Mengi S, De Larochelliere R, Garcia-Labbe D, Dery JP, Poulin A, Larose E, Noel B, Nguyen CM, Paradis JM, Bertrand OF. Randomized Study Comparing Angiography Guidance With Physiology Guidance After PCI: The EASY-PREDICT Study. Circ Cardiovasc Interv. 2025 Jul;18(7):e015165. doi: 10.1161/CIRCINTERVENTIONS.125.015165. Epub 2025 May 21.

MeSH Terms

Conditions

Coronary Artery DiseaseAngina, StableAngina, UnstableMyocardial IschemiaChest Pain

Interventions

Fractional Flow Reserve, Myocardial

Condition Hierarchy (Ancestors)

Coronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesAngina PectorisPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Coronary CirculationBlood CirculationCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Olivier F. Bertrand, MD, PhD

    International Chair on Interventional Cardiology and Transradial Approach

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Principal Investigator

Study Record Dates

First Submitted

May 31, 2021

First Posted

June 18, 2021

Study Start

September 10, 2021

Primary Completion

January 1, 2026

Study Completion

March 1, 2026

Last Updated

March 19, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations